Results 241 to 250 of about 303,574 (253)

Preclinical Rationale for Use of the Clinically Available Multitargeted Tyrosine Kinase Inhibitor Crizotinib in ROS1-Translocated Lung Cancer

Journal of Thoracic Oncology, 2012
Hiroyuki Yasuda, Daniel Costa, Susumu S Kobayashi   +2 more
exaly  

Inhibitors of bruton's tyrosine kinase

2015
DOMINIQUE ROMYR, KONG NORMAN, LOU YAN, LOPEZ-TAPIA FRANCISCO JAVIER, SO SUNG-SAU   +4 more
  +25 more sources

Tyrosine kinase inhibitor induced pancreatitis

Journal of Oncology Pharmacy Practice, 2013
exaly  

INHIBITORS OF BRUTON'S TYROSINE KINASE

2008
HONIGBERG LEE, VERNER ERIK J, BUGGY JOSEPH J, LOURY DAVID J, CHEN WEI   +4 more
openaire   +16 more sources

Heterocyclic inhibitors of tyrosine kinase

2020
HEYMACH JOHN, ROBICHAUX JACQULYNE, NILSSON MONIQUE, JONES PHILIP, CROSS JASON, THEROFF JAY   +5 more
openaire   +3 more sources

BRUTON'S TYROSINE KINASE INHIBITORS

2011
ERLANSON DANIEL A, MARCOTTE DOUG, KUMARAVEL GNANASAMBANDAM, FAN JUNFA, WANG DEPING, CUERVO JULIO H, SILVIAN LAURA, POWELL NOEL, BUI MINNA, HOPKINS BRIAN T, TAVERAS ART, GUAN BING, CONLON PATRICK, ZHONG MIN, JENKINS TRACY J, SCOTT DANIEL, LUGOVSKOY ALEXEY A   +16 more
openaire   +8 more sources

INHIBITORS OF BRUTON'S TYROSINE KINASE

2014
LOPEZ-TAPIA FRANCISCO JAVIER, SO SUNG-SAU, QIAO QI, DOMINIQUE ROMYR   +3 more
openaire   +9 more sources

Inhibitors of Bruton's Tyrosine Kinase

2011
HONIGBERG LEE, VERNER ERIK, BUGGY JOSEPH J, LOURY DAVID, CHEN WEI, MODY TARAK   +5 more
openaire   +9 more sources

Bruton's tyrosine kinase inhibitors

2022
LIAO XIBIN, LV YUBIN
openaire   +2 more sources

OXAZOLE TYROSINE KINASE INHIBITORS

2008
READER JOHN CHARLES, ELLARD JOHN MARK, BOFFEY HELEN, TAYLOR SUSANNE, CARR ANDREW DAVID, CHERRY MICHAEL, WILSON MICHELLE, OWOARE RICHARD BOAKYE   +7 more
openaire   +3 more sources